LiminalX and Rayos Contra Cancer Partner to Train Clinicians on AI

The agreement grants course participants access to the Human Dimension module of LiminalX’s THRIVE platform. This tool evaluates clinical readiness across six key metrics, including technical proficiency, infrastructure, and regulatory awareness. By integrating this framework into their educational curriculum, Rayos Contra Cancer intends to help medical professionals build a shared vocabulary for AI, identify behavioral gaps, and approach new clinical tools with critical judgment.

Benjamin Li, founder of Rayos Contra Cancer, stated that the initiative provides a necessary framework for clinicians working in limited-resource settings to remain proactive as technology advances. The THRIVE platform assigns each participant a Human Readiness Level score, which provides a roadmap for both individual and organizational development. According to LiminalX founder Paul Naine, the collaboration underscores a commitment to ensuring that safe, informed AI adoption is accessible to medical teams regardless of geographic or financial constraints.